Patient Leaflet Updated 26-Feb-2020 | Ranbaxy (UK) Limited a Sun Pharmaceutical Company
Bicalutamide 150 mg film-coated tablets
Bicalutamide 150 mg film-coated tablets
1. What Bicalutamide is and what it is used for
2. What you need to know before you take Bicalutamide
3. How to take Bicalutamide
4. Possible side effects
5. How to store Bicalutamide
6. Contents of the pack and other information
Bicalutamide is one of a group of medicines called non-steroidal anti-androgens.
Bicalutamide 150 mg can be used alone but can also be given as part of a combination treatment to patients that have had their prostate removed. Additionally in combination with radiation therapy for the treatment of prostate cancer, whereby the cancer has spread from the capsule of the prostate gland to the close surrounding tissue. These patients are at high risk for the cancer to spread.
The active substance bicalutamide blocks the undesired effect of a chemical made by a male sex gland (androgens) and inhibits cell growth in the prostate in this way.
Bicalutamide should not be taken by women or must not be given to children or adolescents.
Talk to your doctor or pharmacist before taking Bicalutamide.
Bicalutamide must not be given to children and adolescents.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Do not take Bicalutamide if you are already taking any of the following medicines:
Bicalutamide might interfere with some medicines used to treat heart rhythm problems (e.g. quinidine, procainamide, amiodarone and sotalol) or might increase the risk of heart rhythm problems when used with some other drugs (e.g. methadone (used for pain relief and part of drug addiction detoxification), moxifloxacin (an antibiotic), antipsychotics used for serious mental illnesses).
If you take Bicalutamide together with one of the following medicines, the effect of bicalutamide as well as the other medicine may be influenced. Please speak to your doctor before taking any of these medicines together with Bicalutamide:
Bicalutamide can be taken before, during or after a meal, but also you can take this medicine without food. The film-coated tablet should be swallowed with some water or another liquid.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Bicalutamide is contra-indicated in females and must not be given to pregnant women or breast-feeding mothers.
Bicalutamide 150 mg may induce a period of subfertility or infertility in man.
Bicalutamide is unlikely to affect your ability to drive or to operate machinery. However, some people may occasionally feel drowsy when taking bicalutamide.
If you suffer from drowsiness you would be best advised not to carry out such tasks. However if you still drive a car or use machines you should exercise extra caution.
Avoid direct exposure to excessive sunlight or UV-light while you are taking Bicalutamide.
Bicalutamide 150 mg film-coated tablets contain lactose monohydrate, which is a type of sugar.
If you have been told by your doctor that you have an intolerance to some sugars, such as lactose, contact your doctor immediately.
Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
The recommended dose is one tablet once daily.
Try to take your tablet at the same time each day. Swallow the tablet whole with some liquid.
This medicine is not recommended for patients under the age of 18 years.
If you have taken too many tablets contact your doctor or the nearest hospital as soon as possible.
Take with you the remaining tablets or the pack so the doctor can identify what you have taken.
If you forget to take your daily dose, skip it when you remember it and wait until the next administration time. Do not take a double dose to make up for a forgotten dose. If you are worried, ask your doctor or pharmacist for advice.
Do not stop taking your film-coated tablets even if you feel healthy, unless so advised by your doctor.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
These are uncommon (may affect up to 1 in 100 users). The symptoms can include sudden onset of:
If this happens to you, see a doctor straight away.
Common (may affect up to 1 in 10 users)
Uncommon (may affect up to 1 in 100 users)
Not known (frequency cannot be estimated from the available data)
Very common (may affect more than 1 in 10 users)
Common (may affect up to 1 in 10 users)
Rare (may affect up to 1 in 1,000 users)
Your doctor may do blood tests to check for any changes to your blood.
Do not be concerned by this list of possible side effects. You may not get any of them.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep out of the sight and reach of children.
This medicine does not require any special storage conditions.
Do not use Bicalutamide after the expiry date which is stated on the blister and carton after “EXP”. The expiry date refers to the last day of that month.
Do not throw away any medicine via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Bicalutamide 150 mg film-coated tablet is a white to off white, circular, biconvex, film-coated tablet debossed with ‘507’ on one side and plain on the other side, and contains 150 mg bicalutamide.
Bicalutamide 150 mg film-coated tablets are available in packs of 28, 30 and 84 tablets.
Not all pack sizes may be marketed.
This medicinal product is authorised in the Member States of the EEA under the following names:
Italy Bicalutamide SUN 150 mg compresse rivestite con film
United Kingdom Bicalutamide 150 mg film-coated tablets
This leaflet was last revised in 02/2018.
V015
6-9 The Square, Stockley Park, Uxbridge, UB11 1FW, UK
+44 (0) 208 848 5052